2021 ASM Program

ANZSN Annual Scientific Meeting Online Provisional Program

30th August – 1st September

Registration to the online ASM includes access to the full program below, the Networking Hub, Exhibition Hall, Resource Gallery and all virtual networking sessions. Attendees do not need to identify which sessions they wish to attend before the event.  Click here to register.

The ASM aims to provide all sessions on-demand to registered delegates for a 3 months post event, dependent on speaker consent.  Where consent has not been received and the session will only be available live on the day of presentation and this will be indicated in the program below by 23rd August 2021.

Program times are listed in AEST. To convert program times to your timezone, CLICK HERE

 

Monday, 30th August 2021

0900-0930 Platform Orientation & Exhibition Open
0930-0955 ICEBREAKER DELEGATE NETWORKING
1000 – 1115 PLENARY #1
Chair: Neil BoudvilleANZSN President
1000-1015 Opening Address
Neil Boudville, President, ANZSN

1015-1115 Plenary Speaker
Dr Alessia Fornoni, USA

1115-1145 Refreshment & Exhibition Break
  1145-1315 CONCURRENT SESSION #1
TIME ETHICAL DECISION MAKING IN NEPHROLOGY TOM BARBOUR MEMORIAL SESSION BASIC SCIENCE SYMPOSIUM
AKI – CKD & BACK AGAIN
IMMUNITY & INFLAMMATION
1145-1215 To be advised
Dominique Martin
INTRODUCTION
Nigel Toussaint
TUBULAR ENERGY METABOLISM IN THE AKI-CKD SPECTRUM
Samir Parikh, USA
To be advised
Menna Clatworthy, UK
1215-1245 To be advised
Kathryn Ducharlet
To be advised RENAL REPLACEMENT THERAPY IN ACUTELY ILL PATIENTS
Emily See
To be advised
1245-1315 To be advised
Ezra Gabbay
TOWARDS PERSONALIZED MEDICINE IN IgA NEPHROPATHY
Sean Barbour, CAN
KIDNEY INJURY
David Nikolic-Paterson
IMMUNITY AND INFLAMMATION IN THE KIDNEY
Edward Smith
1315-1340 Refreshment & Exhibition Break
1340- 1550 PLENARY #2
YOUNG INVESTIGATOR AWARD
BASIC SCIENCE
INABILITY TO INCREASE FATTY ACID OXIDATION WORSENS ACUTE KIDNEY INJURY AND IMPACTS THE BENEFIT OF METFORMIN
Geoffrey Harley
ADOPTIVE TOLEROGENIC DENDRITIC CELL THERAPY PROTECTS AGAINST RENAL ISCHEMIA REPERFUSION INJURY
Jennifer Li
TARGETING CD47 PROTECTS AGAINST CARDIORENAL SYNDROME
Kate Trinh
ROLE OF DNA DAMAGE RESPONSE (DDR) SIGNALLING IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Jennifer Zhang
CLINICAL SCIENCE
MACHINE LEARNING IMPROVES UPON CLINICIANS’ PREDICTION OF END-STAGE KIDNEY FAILURE
Daniel Christiadi
CAN PODOCYTE NUMBER AND DENSITY PREDICT THE RESPONSE TO THERAPY IN PATIENTS WITH PRIMARY FSGS?
Natasha De Zoysa
LESSONS FROM A 10-YEAR RETROSPECTIVE REVIEW OF PANCREAS TRANSPLANTATION IN AUSTRALIA AND NEW ZEALAND
Jonathan Ling
TRIMETHOPRIM–SULFAMETHOXAZOLE PHARMACOKINETIC EVAULATION IN ADULT KIDNEY TRANSPLANT RECEIPIENTS
Carla Scuderi
1550-1615 Refreshment & Exhibition Break
  1615-1745 CONCURRENT SESSION #2
TIME KIDNEY HEALTH AUSTRALIA
CLINICAL SCIENCE AWARD SESSION

NEPHROLOGY LESS TRAVELLED
MINI ORAL SESSION #1
INTERVENTIONAL NEPHROLOGY
MINI ORAL SESSION #2
TRANSPLANTATION
1615-1630 THE LAST 1000 DAYS WITH CHRONIC KIDNEY DISEASE: THE HEALTH CARE BURDEN
Matthew Jose
TARGETING THE GUT TO PROTECT THE KIDNEYS: LESSONS FROM EXPERIMENTAL MEDICINE
Melinda Coughlan

LONG TERM OUTCOME OF ENDOVASCULAR INTERVENTIONS IN PROLONGING SURVIVAL OF ARTERIO-VENOUS VASCULAR ACCESS IN DIALYSIS PATIENTS-CENTRAL AUSTRALIAN INTERVENTIONAL NEPHROLOGY EXPERIENCE
David Fernandes
DO DECISION AIDS HELP PEOPLE WHO ARE FACING DECISIONS ABOUT SOLID ORGAN TRANSPLANTATION? A SYSTEMATIC REVIEW
Georgina Irish
OUTCOME OF ENDOVASCULAR THROMBECTOMIES IN PROLONGING THE SURVIVAL OF ARTERIO-VENOUS VASCULAR ACCESS -A CENTRAL AUSTRALIAN EXPERIENCE
David Fernandes
OUTCOMES FOR LIVE KIDNEY DONORS FOLLOWING NEPHRECTOMY IN AOTEAROA NEW ZEALAND: THE LIVE DONATE NZ STUDY
Lai Chan
1630-1645 COGNITIVE AND ACADEMIC OUTCOMES IN CHILDREN WITH CHRONIC KIDNEY DISEASE (CKD) – A LONGITUDINAL ANALYSIS OF THE KIDS IN THE CKD STUDY
Siah Kim

EARLY MATURATION OUTCOMES OF RADIOCEPHALIC AND BRACHIOCEPHALIC ARTERIOVENOUS FISTULAS
Janelle Prunster
PATIENT EXPERIENCE OF THE KIDNEY TRANSPLANT WAITLIST: AN AUSTRALIAN COHORT STUDY
Nicole De La Mata
SVC ANOMALIES ENCOUNTERED IN INTERVENTIONAL NEPHROLOGY: A CASE SERIES
Zhuo Lin Ng
TRANSPLANT RECIPIENTS’ UNDERSTANDING AND ATTITUDES TOWARDS THE COVID-19 VACCINE
Dhaksha Tharmaraj
HAEMODIALYSIS GENETICS
1645-1700 REDUcing THE BURDEN OF DIALYSIS CATHETER ComplicaTIOns: A NATIONAL APPROACH (REDUCCTION)
Sradha Kotwal
TARGETING RENAL MEDULLARY HYPOXIA IN CARDIAC SURGERY-ASSOCIATED ACUTE KIDNEY INJURY
Roger Evans

VITAMIN K-DEPENDENT CARBOXYLATION OF GROWTH ARREST-SPECIFIC PROTEIN 6 IS ASSOCIATED WITH THE RISK OF CALCIPHYLAXIS IN HAEMODIALYSIS PATIENTS
Parul Bali
THE EMERGING ROLE OF WHOLE GENOME INVESTIGATION TO IDENTIFY UNDETECTED NEPHROPATHIES – THE HIDDEN STUDY
Andrew Mallett
1700-1715 KIDNEY TRANSPLANT OUTCOMES AMONG ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE – THE GAP IS CLOSING
Stephen McDonald

EFFECT OF FRAILTY ON MORTALITY IN HAEMODIALYSIS PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT IN CENTRAL AUSTRALIA: A SINGLE CENTRE PROSPECTIVE COHORT STUDY
Nayar Sajith

MITOCHONDRIAL DNA COPY NUMBER VARIATION AS A PREDICTOR OF DISEASE SEVERITY IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Sayanthooran Saravanabavan
EXPERIMENTAL IMMUNOLOGY
PATTERNS OF END-OF-LIFE CARE IN A COHORT OF DIALYSIS PATIENTS
Hannah Douglass-Molloy
CD14 AS A NOVEL PROGNOSTIC MARKER IN CLEAR CELL RENAL CELL CARCINOMA
Retnagowri Rajandram
1715-1730 CHANGES IN COGNITIVE FUNCTION IN PATIENTS WITH END-STAGE KIDNEY DISEASE ON DIALYSIS AND THE EFFECT OF DIALYSIS VINTAGE
Karumathil Murali


To be advised
Hiddo Lambers Heerspink, Netherlands

SYSTEMATIC REVIEW AND META-ANALYSIS ON CARDIOVASCULAR OUTCOMES OF PATIENTS ON DIALYSIS RECEIVING MINERALOCORTICOID RECEPTOR ANTAGONISTS
Edmund Chung
SPLEEN TYROSINE KINASE DELETION IN MYELOID CELLS REDUCES MACROPHAGE INFILTRATION IN ARISTOLOCHIC ACID NEPHROPATHY IN MICE
Xiu Xian Chia
ERYTHROPOIESIS-STIMULATING AGENTS FOR ANAEMIA IN ADULTS WITH CHRONIC KIDNEY DISEASE: AN UPDATED COCHRANE NETWORK META-ANALYSIS
Edmund Chung
AGEING ENHANCES CELLULAR IMMUNITY TO MYELOPEROXIDASE AND EXPERIMENTAL ANTI-MYELOPEROXIDASE GLOMERULONEPHRITIS
Maliha Alikhan
1730-1745 REGIONAL ANAESTHESIA FOR PERCUTANEOUS PERITONEAL DIALYSIS CATHETER INSERTION BY NEPHROLOGISTS USING ULTRASOUND GUIDED RECTUS SHEATH BLOCK
Wai Weng Yeo


TIME TO FIRST INTERVENTION IN HAEMODIALYSIS VASCULAR ACCESS: A SINGLE CENTRE COHORT STUDY
Joshua Lee
INFLAMMASOME SIGNALLING IN HUMAN HYPOXIC CHRONIC KIDNEY DISEASE (CKD)
Kurt Giuliani
1745 ASM Day 1 Concludes

 

 


 

Tuesday, 31st August 2021

0900 Platform & Exhibition Open
0930-0955 ICEBREAKER DELEGATE NETWORKING
1000 – 1100 PLENARY #3
0955-1000 Welcome
1000-1100 Plenary Speaker
NAD+ AND RENAL STRESS DEFENSE – BENCH TO BEDSIDE
Samir Parikh, USA
1100-1130 Refreshment & Exhibition Break
  1130-1300 CONCURRENT SESSION #3
TIME APSN SYMPOSIUM PAEDIATRIC SYMPOSIUM
FROM GENETICS TO GENE THERAPY
INTERVENTIONAL SYMPOSIUM CLINICAL TRIAL UPDATE SYMPOSIUM
1130-1200 UPDATES ON POST INFECTIOUS GN
Rosnawati Yahya
miRNA IN KIDNEY DEVELOPMENT
Jaqueline Ho, USA
PROCEEDURAL CERTIFICATION AND ACCREDITATION IN INTERVENTIONAL NEPHROLOGY
Steve May
CLINICAL TRIALS IN NEPHROLOGY
Meg Jardine


 

AKTN
Carmel Hawley


1200-1230 THERAPEUTIC TARGET FOR MITOCHONDRIA METABOLISM IN KIDNEY DISEASE
Reiko Inagi

STEROID-RESISTANT NEPHROTIC SYNDROME
Hugh McCarthy
To be avised
Catherine Wilkinson
To be avised
David Voss
1230-1300 SOLID ORGAN TRANSPLANT REGISTRY IN ASIA (ASTREG)
Curie Ahn
GENE THERAPY FOR CYSTINOSIS
Stephanie Cherqui
FISTULA CANNULATION: TECHNIQUES AND COMPLICATIONS
Liz Coroneos
1300-1330 Refreshment & Exhibition Break
  1330-1500 CONCURRENT SESSION #4
TIME 1330-1420
SHAUN SUMMERS CLINICAL TRAINEE AWARD 
BASIC SCIENCE AWARD
MINI ORAL SESSION #3
EPIDEMIOLOGY & PUBLIC HEALTH
MINI ORAL SESSION #4
DIABETES/CARDIOVASCULAR/HYPERTENSION
1330-1345

PRESENTATION, PROGNOSIS AN OUTCOME OF PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY IN HUNTER REGION, NSW, AUSTRALIA
Zuo Li
THE TRANSCRIPTION FACTOR JUN DRIVES THE TUBULAR INFLAMMATORY AND FIBROTIC RESPONSE
Sanduni Fernando
DIALYSIS INCIDENCE AND MORTALITY TRENDS FOR MODELLING FUTURE PREVALENCE
Christopher Davies 
CHRONIC KIDNEY DISEASE AND COMORBIDITY IN INDIGENOUS COMMUNITIES OF AUSTRALIA
Vishweswar Chilumkurti
TYPE 3 CARDIORENAL SYNDROME FOLLOWING RAPIDLY PROGRESSIVE MPO-ANCA ASSOCIATED GLOMERULONEPHRITIS: A REPORT OF 2 CASES
Sarah McBride
ASSOCIATION BETWEEN DIALYSIS ACCESS AND DIALYSIS WITHDRAWAL IN THE FIRST 12 MONTHS AFTER DIALYSIS INITIATION
Jenny H Chen
MEDIATORS OF THE EMPAGLIFLOZIN TREATMENT EFFECT ON KIDNEY OUTCOMES IN THE EMPA-REG OUTCOME TRIAL
Meg Jardine 
1345-1400

RENAL OUTCOMES AND CLINICAL PREDICTORS OF MYELOMA CAST NEPHROPATHY IN THE CONTEMPORARY ERA
Chathri Ratnayake
ADAPTIVE VERSUS MALADAPTIVE REPAIR PROFILING OF HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS (PTEC) IN CHRONIC KIDNEY DISEASE (CKD)
Purba Nag
PROGRESSION OF EGFR AND ITS RISK FACTORS AMONG PATIENTS IN THE CKD.QLD REGISTRY, AUSTRALIA
Zaiman Wang
EFFECTS OF PHOSPHATE-LOWERING THERAPY IN NON-DIALYSIS CHRONIC KIDNEY DISEASE – A SYSTEMATIC REVIEW AND META-ANALYSES
Nicole Lioufas
A RETROSPECTIVE OBSERVATIONAL STUDY OF FUNGAL PERITONITIS IN THE WESTERN RENAL SERVICES IN SYDNEY AUSTRALIA
Dharshana Sabanayagam
ACUTE KIDNEY INJURY PREVALENCE IN THE ILLAWARRA SHOALHAVEN LOCAL HEALTH DISTRICT OVER 10 YEARS
Eyra Munzner
ROLE OF NADPH OXIDASE-NOX5 AND ASSOCIATED ROS-SENSITIVE PATHWAYS IN HUMAN DIABETIC KIDNEY DISEASE
Jay Jha
1400-1415


 
PREVALENCE OF LONG TERM METABOLIC, CARDIOVASCULAR, CEREBROVASCULAR AND RENAL DISEASE IN PATIENTS WITH A HYPERTENSIVE DISORDER IN PREGNANCY (HDP) REMOTE FROM PREGNANCY (POMCH)
Jade Schroers
 CHRONIC KIDNEY DISEASE AND OSTEOARTHRITIS: INVESTIGATING A NEW PATHWAY DRIVING DISEASE
Natasha Rogers
PAEDIATRICS  
VALPROIC ACID ATTENUATES DIABETIC KIDNEY DISEASE VIA INHIBITION OF COMPLEMENT
Sih Min Tan
AN AUDIT OF PAEDIATRIC URINARY TRACT INFECTION IN THE TOP END HEALTH SERVICE OF THE NORTHERN TERRITORY OF AUSTRALIA
Carolyn Marshall



1415-1430
TUBERCULOSIS SCREENING PRACTICES AND OUTCOMES IN AN AUSTRALIAN DIALYSIS UNIT
Hannah Wallace

EFFECT OF CISPLATIN-INDUCED DNA DOUBLE-STRAND BREAKS ON THE SELECTIVE LOSS OF CYSTIC EPITHELIAL CELLS
Sayanthooran Saravanabavan
AUDIT OF THE CLINICAL MANAGEMENT OF CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Anju Ramanayake

ACUTE KCL REPLACEMENT DECREASES THE THIAZIDE-SENSITIVE SODIUM CHLORIDE COTRANSPORTER ABUNDANCE AND PHOSPHORYLATION IN HYPERTENSIVE PATIENTS WITH RAISED ALDOSTERONE-TO-RENIN RATIOS (ARRS)
Michael Wu
ANZDATA
1420-1500
EXPERIMENTAL TUBULOINTERSTITIAL DISEASE GENERAL NEPHROLOGY
MUTATION OF REGULATORY PHOSPHORYLATION SITES IN PFKFB2 DOES NOT AFFECT METFORMIN’S PROTECTIVE EFFECTS AGAINST RENAL FIBROSIS
Geoffrey Harley
 
COMPARISON OF MATERNOFETAL OUTCOMES FOR BIRTHS IN WOMEN BEFORE AND AFTER COMMENCEMENT OF KIDNEY REPLACEMENT THERAPY USING LINKED ANZDATA AND PERINATAL DATASETS
Erandi Hewawasam
1430-1445 DIETARY RESISTANT STARCH ALTERS GUT MICROBIOTA, INTESTINAL CLAUDIN-7 EXPRESSION AND ALBUMINURIA IN DIABETIC MICE
Matthew Snelson
AMILORIDE REDUCES LITHIUM INDUCED INTERSTITIAL FIBROSIS AND INFLAMMATION
Mehta Paulomi
MEDICATION NON-ADHERENCE IN PATIENTS WITH KIDNEY DISEASE: IMPORTANCE OF DEPRESSION, HEALTH LITERACY AND PILL BURDEN
Karumathil Murali
BAICALEIN ATTENUATES ADENINE-INDUCED FERROPTOSIS IN HUMAN KIDNEY PRIMARY PROXIMAL TUBULAR EPITHELIAL CELLS (PTEC) VIA INDUCTION OF ANTIOXIDANT PATHWAYS
Muhammad Ali Khan
CENTRAL AUSTRALIA TELENEPHROLOGY REVIEW PROJECT
Megan Brown
1445-1500 INTERLEUKIN-33 EXPANSION OF ILC2 IN B CELL ACTIVATING FACTOR (BAFF) TRANSGENIC MICE EXACERBATES IGA GLOMERULONEPHRITIS
Yuan Min Wang


TRANSCRIPTIONAL ANALYSIS OF GROWING KIDNEYS FOLLOWING UNILATERAL NEPHRECTOMY
Darling Rojas-canales
MORTALITY OUTCOMES FOR MĀORI REQUIRING RENAL REPLACEMENT THERAPY DURING CRITICAL ILLNESS: A SINGLE UNIT STUDY IN AOTEAROA NEW ZEALAND
M Atif Mohd Slim
1500-1515 Refreshment & Exhibition Break
1515-1615 PLENARY #4

1515-1615 Plenary Speaker

VASCULAR REMODELING IN HYPERTENSION AND IMMUNE MECHANISMS
Ernesto Schiffrin, Canada

1615 – 1645 DELEGATE GROUP NETWORKING
1645 ASM Day 2 Concludes

 


 

Wednesday, 1st September 2021

0830 Platform & Exhibition Open
0900-0930 ICEBREAKER DELEGATE NETWORKING
  0930- 1100 CONCURRENT SESSION #5
TIME UPDATES IN NEPHROLOGY SYMPOSIUM BIG DATA IN NEPHROLOGY SYMPOSIUM EQUITY & DIVERSITY SYMPOSIUM TRANSPLANTATION UPDATE SYMPOSIUM
0930-1000 COVID VACCINATION AND KIDNEY DISEASE
Janine Trevillyan
To be advised
Stephen McDonald
INEQUITY IN MAORI/FIRST NATIONS HEALTHCARE DELIVERY
Tania Huria
LATE ALLOGRAFT REJECTIONG – WHAT TO DO
Brian Nankivell
1000-1030 CARI GUIDELINES
David Tunnicliffe
HARNESSING BIOINFORMATICS IN KIDNEY
Jean Yang

GENDER EQUITY IN RESEARCH AND CLINICAL MEDICINE
Alessia Fornoni
KIDNEY REGROWTH AFTER DONATION
Jonathan Gleadle
INVOLVING CONSUMERS IN CLINICAL PRACTICE GUIDELINES
Nicki Sholes-Robertson, Chandana Guha
1030-1100
NATIONAL BEST PRACTICE GUIDELINES FOR ENVIRONMENTALLY SUSTAINABLE DESIGN (ESD) OF DIALYSIS UNITS
Matthew Sypek
SPATIAL TRANSCRIPTOMIC AND THE KIDNEY
Quan Nguyen
UPDATE FROM THE EQUITY, DIVERSITY AND INCLUSIVITY COMMITTEE
Anna Francis
CARDIOVASCULAR DISEASE AND KIDNEY TRANSPLANTATION
Helen Pilmore
1100-1130 Refreshment & Exhibition Break
  1130-1300 CONCURRENT SESSION #6
TIME HAEMODIALYSIS – THE FORGOTTEN ART
MATERNAL-FETAL INTERFACE & THE KIDNEY
MINI ORAL SESSION #5
TRANSPLANTATION
MINI ORAL SESSION #6
HEALTH SERVICES RESEARCH
1130-1200 DIETARY CONSIDERATIONS IN HEMODIALYSIS PATIENTS
Kelly Lambert
MECHANISMS UNDERLYING HYPERTENSION AND PRE-CLAMPSIA IN PREGNANCY
Anne-Marie Hennessy
CHARACTERISTICS OF THE GASTROINTESTINAL MICROBIOTA IN PAIRED LIVE KIDNEY DONORS AND RECIPIENTS
Samuel Chan
AN OVERVIEW OF COST, HOSPITALISATIONS AND LENGTH OF STAY IN PRE-TERMINAL CKD.QLD REGISTRY PATIENTS ACROSS QUEENSLAND
Vishal Diwan
RANGE AND CONSISTENCY OF INFECTION OUTCOMES REPORTED IN TRIALS CONDUCTED IN KIDNEY TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW
Samuel Chan
CHARACTERISTICS AND OUTCOMES OF PERSONS WITH CHRONIC KIDNEY DISEASE (CKD) BY INDIGENOUS STATUS, A CKD.QLD REGISTRY STUDY
Vishal Diwan
SURVIVAL BENEFIT OF DECEASED DONOR KIDNEY TRANSPLANTATION FOR ABORIGINAL AND TORRES STRAIT ISLANDER AUSTRALIANS
Samantha Bateman
INFORMING THE EVIDENCE-PRACTICE GAP ABOUT FRAILTY DETECTION MEASURES AMONG ADULT ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE WITH ADVANCED KIDNEY DISEASE: THE LIVE STRONG, COVID-SAFE AND FRAILTY FREE AFTER STARTING DIALYSIS PROJECT
Richard Modderman
1200-1230 CKD AND SLEEP DISTURBANCES
Mark Unruh, USA
PRE-ECLAMPSIA
Angela Makris

PLASMA CELL-FREE DNA AND SIX-YEAR OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS
Alison Graver
UNDERSTANDING TIME TRENDS IN RISK OF BIAS AND SMALL STUDY EFFECTS IN KIDNEY DISEASE: A META-EPIDEMIOLOGICAL STUDY
Hannah Tait
ASSESSMENT OF GLYCAEMIC LEVELS AND OPTIMISATION OF PATIENT EXPERIENCE POST RENAL TRANSPLANTATION USING FLASH GLUCOSE MONITORING
Awf Abdulrahman Shaban
SURVEY OF RENAL PATIENTS AND DIETITIANS TO DETERMINE WHAT NUTRITIONAL OUTCOMES MATTER TO PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Maria Chan
MELANOMA IN SOLID ORGAN DONORS AND TRANSPLANT RECIPIENTS: TRANSMISSION RISK AND MISSED OPPORTUNITIES
Brenda Maria Rosales
ACUTE KIDNEY INJURY AMONG PATIENTS WITH PRETERMINAL CHRONIC KIDNEY DISEASE IN DIFFERENT HEALTH CARE SETTINGS, QUEENSLAND
Jenny Zhang
1230-1300 VASCULAR ACCESS AND INCREMENTAL START HEMODIALYSIS
Andrea
 Vicelli
PREGNANCY IN DIALYSIS
Shilpa Jesudason
MERKEL CELL CANCER IN KIDNEY TRANSPLANT RECIPIENTS: ANALYSIS OF THE AUSTRALIAN AND NEW ZEALAND DIALYSIS AND TRANSPLANT (ANZDATA) REGISTRY
Rachel Yi Ping Tan
SCOPING REVIEW OF RECOMMENDATIONS REGARDING PHYSICAL ACTIVITY AND EXERCISE FOR PEOPLE UNDERTAKING DIALYSIS
Kelly Lambert

NON-MELANOMA SKIN CARCINOMA BEFORE AND AFTER EXPOSURE TO IMMUNOSUPPRESSIVE TREATMENT AMONG PATIENTS WITH GLOMERULAR DISEASE AND RENAL TRANSPLANT RECIPIENTS
Zaw Thet
PERITONEAL DIALYSIS
PERITONITIS AS A RISK FACTOR FOR CARDIOVASCULAR MORTALITY IN PERITONEAL DIALYSIS – A COHORT STUDY
Hicham Cheikh Hassan
CHARACTERISTICS AND EARLY OUTCOMES OF PATIENTS REFERRED FOR SIMULTANEOUS PANCREAS/KIDNEY TRANSPLANTATION (SPKT) TO A NATIONAL PANCREAS TRANSPLANT UNIT
Laura Bywater
WHAT ACTUALLY HAPPENS AT HOME DURING PERITONEAL DIALYSIS? LINKING ANZDATA AND SHARESOURCE DATA
Stephen McDonald

SUITABLE DECEASED DONOR PANCREATA THAT ARE NOT BEING TRANSPLANTED IN AUSTRALIA AND NEW ZEALAND
Jonathan Ling
ENVIRONMENTAL SUSTAINABILITY
A SURVEY OF ENVIRONMENTAL SUSTAINABILITY PRACTICES IN DIALYSIS UNITS IN AUSTRALIA AND NEW ZEALAND
Ben Talbot
1300-1330 Refreshment & Exhibition Break
1330-1500 PLENARY #5
Focus on First Nations
REPORT FROM THE NATIONAL INDIGENOUS KIDNEY TRANSPLANT TASKFORCE
Jaquelyne Hughes & Stephen McDonald
INDIGENOUS PATIENTS – HOW WE NEED TO DO BETTER
Curtis Walker
RETURN TO COUNTRY STUDY
Yomei Jones & Cilla Preece
1500-1530 Refreshment & Exhibition Break
1530-1700 PLENARY #6
Chair: David Johnson, Incoming ANZSN President
Award Presentations
Leadership Award
TJ Neale Award Presentation
Meg Jardine, NSW
Jacquot Award
Paul Lawton & Karen Keung
1700-1705 Changeover Break
1705-1730 PLENARY #7
Chair: David Johnson, Incoming ANZSN President
President’s Overview of 2021 ASM – highlights, hot topics and future directions

Award Presentations
Handover & Closing
1730 ASM Day 3 Concludes

 

Recent Comments
    Categories